Who owns Septanazal?
Septanazal is owned by Krka (Slovenia, LJSE: KRKG).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Krka 2025 Annual Report, Krka, d. d., Novo mesto, 23 March 2026. Last checked .
Key facts
- Current owner
- Krka, tovarna zdravil, d. d., Novo mesto reported
- Owner HQ
- 🇸🇮 Slovenia, Novo mesto
- Origin
- 🇸🇮 Slovenia
- Category
- Consumer health › Over-the-counter medicine › Cold
- Parent ticker
- LJSE: KRKG WSE: KRK
- Last verified
- · 1 sources
About Septanazal
Septanazal is a nasal decongestant spray combining xylometazoline with dexpanthenol, sold in separate adult and children's versions in more than thirty countries, Spain among them since 2024. Krka reports it as one of the leading sprays in its category in Slovenia, Latvia and Lithuania in 2025, and says it outsold every competing product in Moldova, where its share passed twenty per cent. It is called Septanasal in some markets.
Ownership timeline of Septanazal
Where Septanazal sits in Krka
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Krka ownership tree →
See the full Krka brand portfolio (18) →
Other brands owned by Krka
Krka controls 18 brands on Brandtree, 8 of them in consumer health.
Also in consumer health
Other brands in cold, and who owns them
Krka has more brands in cold on Brandtree than any other owner: 5 of 36.
| Brand | Owner | Owner based in |
|---|---|---|
| Breathe Right | Prestige Consumer Healthcare | 🇺🇸 United States |
| Lemsip | Reckitt | 🇬🇧 United Kingdom |
| Covonia | STADA | 🇩🇪 Germany |
| Dimestil | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| HealthCareAisle | Dr. Reddy's | 🇮🇳 India |
| Tukol | Genomma Lab | 🇲🇽 Mexico |
| Benadryl | Kenvue | 🇺🇸 United States |
| Allergosan | Sopharma | 🇧🇬 Bulgaria |
About the owner: Krka
Krka is a publicly listed company headquartered in Novo mesto, Slovenia, founded in 1954. Brandtree records 18 brands under its control, and it is listed as LJSE: KRKG and WSE: KRK.
Krka is a Slovenian generic pharmaceutical maker established in Novo mesto in 1954, listed in Ljubljana since 1997 and dual-listed in Warsaw since 2012. Group revenue was €2,041.0 million in 2025 and net profit €403.7 million. Prescription medicines are the bulk of it, but Krka also sells non-prescription products and animal health products, and its Slovenian subsidiary Terme Krka runs four health resorts. At home it is the largest supplier of medicines by value and says one in every five medicines sold in Slovenia is its own.
🇸🇮 Septanazal and other Slovenian brands
Brandtree records a controlling owner for 31 brands that began in Slovenia. 10 of them (32%) are now controlled by a company headquartered in another country; Septanazal is not one of them.
Frequently asked questions
Who is the parent company of Septanazal?
The parent company of Septanazal is Krka, a publicly listed company headquartered in Slovenia.
Is Septanazal Slovenian?
Yes. Septanazal originated in Slovenia and its owner, Krka, is also headquartered in Slovenia.
Is Septanazal still owned by Krka?
Yes. As of 16 September 2026, Septanazal is still owned by Krka. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Krka 2025 Annual Report — Krka, d. d., Novo mesto, Annual report, published 23 March 2026; retrieved 16 September 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.